WHO Pharmaceuticals Newsletter
(No. 4, 2009)
This issue includes regulatory decisions taken on antipsychotics, clopidogrel, erlotinib and other medicines and safety information on more than 10 products. The Feature article is on the Inspection of Bio-Equivalence Studies carried out by the WHO Programme for the Prequalification of Medicines. We hope the information will be useful and relevant to you in your work.
The third WHO training course on Pharmacovigilance (for Francophone countries) was held in June 2009 at Rabat, Morocco. This was hosted by the Moroccan Pharmacovigilance Centre. In July 2009, WHO held the third advanced training course in Maputo, Mozambique, for Consultants in Pharmacovigilance for Africa. We will include a report in the next issue. These training courses and workshops have been very important in building capacity and in strengthening ongoing initiatives in pharmacovigilance in sub-Saharan Africa.